{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:17:04Z","timestamp":1790032624271,"version":"4.0.1"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9151-17","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:14:04Z","timestamp":1507673644000},"page":"127-130","source":"Crossref","is-referenced-by-count":13,"title":["Severe Infection of &lt;i&gt;Pseudomonas aeruginosa&lt;\/i&gt; during Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria"],"prefix":"10.2169","volume":"57","author":[{"given":"Toru","family":"Kawakami","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukifumi","family":"Kurasawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Nishina","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Senoo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Senoo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"},{"name":"Department of Biomedical Laboratory Science, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106: 3699-3709, 2005.","DOI":"10.1182\/blood-2005-04-1717"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood 113: 6522-6527, 2009.","DOI":"10.1182\/blood-2009-03-195966"},{"key":"3","unstructured":"3. Ricklin D, Lambris JD. Complement-targeted therapeutics. Nat Biotechnol 25: 1265-1275, 2007."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Brodsky RA, Young NS, Antonioli E, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 111: 1840-1847, 2008.","DOI":"10.1182\/blood-2007-06-094136"},{"key":"5","unstructured":"5. Hillmen PYN, Schubert J, Brodsky RA, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355: 11, 2006."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Kelly RJ, Hill A, Arnold LM, et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117: 6786-6792, 2011.","DOI":"10.1182\/blood-2011-02-333997"},{"key":"7","unstructured":"7. Benamu E, Montoya JG. Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis. Curr Opin Infect Dis 29: 319-329, 2016."},{"key":"8","unstructured":"8. Webb BJ, Healy R, Child B, Majers J, Anand S, Gouw L. Recurrent infection with <i>Pseudomonas aeruginosa<\/i> during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient. Transpl Infect Dis 18: 312-314, 2016."},{"key":"9","unstructured":"9. Vellanki VS, Bargman JM. <i>Aspergillus niger<\/i> peritonitis in a peritoneal dialysis patient treated with eculizumab. Ren Fail 36: 631-633, 2014."},{"key":"10","unstructured":"10. Gomez-Cibeira E, Ivanovic-Barbeito Y, Gutierrez-Martinez E, et al. Eculizumab-related progressive multifocal leukoencephalopathy. Neurology 86: 399-400, 2016."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet 373: 759-767, 2009.","DOI":"10.1016\/S0140-6736(09)60001-5"},{"key":"12","unstructured":"12. Patir P, Isik Y, Turk Y, et al. Necrotizing fasciitis in paroxysmal nocturnal hemoglobinuria. Case Rep Hematol 2015: 908087, 2015."},{"key":"13","unstructured":"13. Ninomiya H, Obara N, Chiba S, et al. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan. Int J Hematol 104: 548-558, 2016."},{"key":"14","unstructured":"14. Younger JG, Shankar-Sinha S, Mickiewicz M, et al. Murine complement interactions with <i>Pseudomonas aeruginosa<\/i> and their consequences during pneumonia. Am J Respir Cell Mol Biol 29: 432-438, 2003."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_9151-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T04:46:49Z","timestamp":1515214009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_9151-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9151-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}